Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 3473330)

Published in Neuropsychopharmacology on July 18, 2012

Authors

Chiara Giuliano1, Trevor W Robbins, Pradeep J Nathan, Edward T Bullmore, Barry J Everitt

Author Affiliations

1: Behavioral and Clinical Neuroscience Institute and Department of Experimental Psychology, University of Cambridge, Cambridge, UK. cg451@cam.ac.uk

Articles citing this

The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours. Psychopharmacology (Berl) (2014) 2.01

Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories--indications for novel treatments of addiction. Eur J Neurosci (2014) 1.18

Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol Psychiatry (2012) 1.06

Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness "liking" and "wanting". J Neurosci (2014) 1.01

Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese people. Biol Psychiatry (2012) 0.96

Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism. Psychopharmacology (Berl) (2013) 0.94

Pathological Overeating: Emerging Evidence for a Compulsivity Construct. Neuropsychopharmacology (2016) 0.86

On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination. Psychopharmacology (Berl) (2013) 0.85

Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals. Psychopharmacology (Berl) (2012) 0.84

Opioidergic and dopaminergic manipulation of gambling tendencies: a preliminary study in male recreational gamblers. Front Behav Neurosci (2013) 0.84

Mu opioid receptor antagonism in the nucleus accumbens shell blocks consumption of a preferred sucrose solution in an anticipatory contrast paradigm. Neuroscience (2013) 0.82

Involvement of Endogenous Enkephalins and β-Endorphin in Feeding and Diet-Induced Obesity. Neuropsychopharmacology (2015) 0.80

The uncompetitive N-methyl-D-aspartate antagonist memantine reduces binge-like eating, food-seeking behavior, and compulsive eating: role of the nucleus accumbens shell. Neuropsychopharmacology (2015) 0.80

Convergent dysregulation of frontal cortical cognitive and reward systems in eating disorders. Med Sci Monit (2013) 0.79

The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice. Psychopharmacology (Berl) (2015) 0.79

The role of the opioid system in binge eating disorder. CNS Spectr (2015) 0.79

Sigma-1 receptor mediates acquisition of alcohol drinking and seeking behavior in alcohol-preferring rats. Behav Brain Res (2015) 0.77

Intermittent-access binge consumption of sweet high-fat liquid does not require opioid or dopamine receptors in the nucleus accumbens. Behav Brain Res (2015) 0.77

Seeking behavior, place conditioning, and resistance to conditioned suppression of feeding in rats intermittently exposed to palatable food. Behav Neurosci (2015) 0.77

Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction. Psychopharmacology (Berl) (2014) 0.77

Alleviating waiting impulsivity and perseverative responding by μ-opioid receptor antagonism in two inbred mouse strains. Psychopharmacology (Berl) (2014) 0.77

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype. Neuropsychopharmacology (2016) 0.76

The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking. Neuropsychopharmacology (2015) 0.76

Obesity: Current and potential pharmacotherapeutics and targets. Pharmacol Ther (2016) 0.75

Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone. Sci Rep (2017) 0.75

Articles cited by this

A neural substrate of prediction and reward. Science (1997) 31.30

Getting formal with dopamine and reward. Neuron (2002) 9.83

Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci (1992) 5.27

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA (2005) 4.64

Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev (2004) 4.11

Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J Abnorm Psychol (2008) 3.20

Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness? J Neurosci (2005) 3.10

Reward processing by the opioid system in the brain. Physiol Rev (2009) 2.46

Modulation of appetite by gonadal steroid hormones. Philos Trans R Soc Lond B Biol Sci (2006) 2.30

Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J Neurosci (2007) 2.18

Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol (2004) 2.17

The ventral pallidum and hedonic reward: neurochemical maps of sucrose "liking" and food intake. J Neurosci (2005) 2.10

The ventral tegmental area is required for the behavioral and nucleus accumbens neuronal firing responses to incentive cues. J Neurosci (2004) 1.97

Conditioned cues elicit feeding in sated rats: a role for learning in meal initiation. Science (1983) 1.86

Nucleus accumbens opioid, GABaergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat. Behav Neurosci (2003) 1.85

Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther (1998) 1.73

The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets (2002) 1.66

Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci (2003) 1.54

Distinct opioid circuits determine the palatability and the desirability of rewarding events. Proc Natl Acad Sci U S A (2009) 1.51

Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food. Neuropsychopharmacology (2007) 1.38

Learned contextual cue potentiates eating in rats. Physiol Behav (2006) 1.37

Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides (2004) 1.35

Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat (2007) 1.18

Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatum. J Neurosci (2010) 1.18

Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol Behav (1992) 1.17

Central opioids and consumption of sweet tastants: when reward outweighs homeostasis. Physiol Behav (2007) 1.15

Chocolate craving and liking. Appetite (1991) 1.14

Exploring comfort food preferences across age and gender. Physiol Behav (2003) 1.12

Ovarian hormones inhibit fat intake under binge-type conditions in ovariectomized rats. Physiol Behav (2008) 1.08

Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist. J Pharmacol Exp Ther (2011) 1.07

Bingeing rats: a model of intermittent excessive behavior? Appetite (2005) 1.07

Differential regulation of the consummatory, motivational and anticipatory aspects of feeding behavior by dopaminergic and opioidergic drugs. Neuropsychopharmacology (2005) 1.06

Selective excitotoxic lesions of the hippocampus and basolateral amygdala have dissociable effects on appetitive cue and place conditioning based on path integration in a novel Y-maze procedure. Eur J Neurosci (2006) 1.06

Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry (2011) 1.06

From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour. Int J Neuropsychopharmacol (2009) 1.03

Nucleus accumbens opioids regulate flavor-based preferences in food consumption. Neuroscience (2006) 1.03

Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect. Physiol Behav (1997) 1.01

Decreased motivation to eat in mu-opioid receptor-deficient mice. Eur J Neurosci (2007) 1.01

Potency of naloxone's anorectic effect in rats is dependent on diet preference. Am J Physiol (1996) 0.99

An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am J Physiol (1986) 0.99

Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel μ-opioid receptor inverse agonist. J Clin Pharmacol (2011) 0.98

Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects. J Clin Psychopharmacol (2000) 0.98

Reinforcing effects of stimulants in humans: sensitivity of progressive-ratio schedules. Exp Clin Psychopharmacol (2008) 0.97

Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens. Neuroscience (2010) 0.96

Naloxone effects on sucrose-motivated behavior. Psychopharmacology (Berl) (1996) 0.96

Signalling and incentive processes in instrumental reinforcer devaluation. Q J Exp Psychol B (1992) 0.94

Studies of instrumental behavior with sexual reinforcement in male rats (Rattus norvegicus): I. Control by brief visual stimuli paired with a receptive female. J Comp Psychol (1987) 0.93

Alterations in food intake elicited by GABA and opioid agonists and antagonists administered into the ventral tegmental area region of rats. Physiol Behav (2002) 0.91

Binge eating in rats produced by combining dieting with stress. Curr Protoc Neurosci (2006) 0.90

Investigation of the devaluation interpretation of anticipatory negative contrast. J Exp Psychol Anim Behav Process (1995) 0.90

Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats. Int J Obes (Lond) (2010) 0.88

Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection. Alcohol (2009) 0.88

Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans. Am J Physiol (1991) 0.85

Opioid receptors modulate recovery from consummatory successive negative contrast. Behav Brain Res (2005) 0.85

Opiate blockade inhibits saccharin intake and blocks normal preference acquisition. Pharmacol Biochem Behav (1986) 0.84

Individual effects of estradiol and progesterone on food intake and body weight in ovariectomized binge rats. Physiol Behav (2011) 0.79

Articles by these authors

Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18

Inhibition and the right inferior frontal cortex. Trends Cogn Sci (2004) 9.78

Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev (2002) 8.78

Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75

Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci (2003) 5.94

Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci (2004) 5.55

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91

Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci (2008) 4.85

Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 4.84

High impulsivity predicts the switch to compulsive cocaine-taking. Science (2008) 4.76

Whole-brain anatomical networks: does the choice of nodes matter? Neuroimage (2009) 4.43

Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev (2004) 4.38

Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science (2004) 4.25

Drug seeking becomes compulsive after prolonged cocaine self-administration. Science (2004) 4.20

Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99

Impulsivity, compulsivity, and top-down cognitive control. Neuron (2011) 3.96

Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron (2008) 3.93

Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry (2004) 3.85

Network-based statistic: identifying differences in brain networks. Neuroimage (2010) 3.60

Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci (2002) 3.50

Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci (2004) 3.48

Involvement of the dorsal striatum in cue-controlled cocaine seeking. J Neurosci (2005) 3.44

Amygdala-frontal connectivity during emotion regulation. Soc Cogn Affect Neurosci (2007) 3.43

Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry (2005) 3.35

Dissociable contributions of the orbitofrontal and infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: further evidence for the functional heterogeneity of the rodent frontal cortex. J Neurosci (2003) 3.29

Human brain networks in health and disease. Curr Opin Neurol (2009) 3.28

Modular and hierarchically modular organization of brain networks. Front Neurosci (2010) 3.06

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain (2009) 3.03

Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev (2006) 2.96

Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci (2007) 2.95

Reconsolidation and extinction of conditioned fear: inhibition and potentiation. J Neurosci (2006) 2.94

Abnormal brain structure implicated in stimulant drug addiction. Science (2012) 2.85

Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol (2013) 2.85

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain (2003) 2.81

Hierarchical modularity in human brain functional networks. Front Neuroinform (2009) 2.76

Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann N Y Acad Sci (2003) 2.70

Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res (2008) 2.61

Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia (2003) 2.55

Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci (2004) 2.52

Serotonin modulates behavioral reactions to unfairness. Science (2008) 2.49

Schizophrenia, neuroimaging and connectomics. Neuroimage (2012) 2.49

Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci (2002) 2.49

Serotonin selectively influences moral judgment and behavior through effects on harm aversion. Proc Natl Acad Sci U S A (2010) 2.47

Beyond threat: amygdala reactivity across multiple expressions of facial affect. Neuroimage (2005) 2.47

Disrupting reconsolidation of drug memories reduces cocaine-seeking behavior. Neuron (2005) 2.44

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44

Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (2006) 2.41

Direct interactions between the basolateral amygdala and nucleus accumbens core underlie cocaine-seeking behavior by rats. J Neurosci (2004) 2.39

Efficient physical embedding of topologically complex information processing networks in brains and computer circuits. PLoS Comput Biol (2010) 2.37

Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci (2004) 2.24

Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry (2011) 2.24

Disrupted modularity and local connectivity of brain functional networks in childhood-onset schizophrenia. Front Syst Neurosci (2010) 2.22

Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci (2003) 2.22

Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology (2009) 2.21

Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry (2013) 2.20

Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation. J Neurosci (2006) 2.19

Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav (2007) 2.19

The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc (2008) 2.17

Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) (2002) 2.17

Network scaling effects in graph analytic studies of human resting-state FMRI data. Front Syst Neurosci (2010) 2.13

Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry (2010) 2.13

Disrupted axonal fiber connectivity in schizophrenia. Biol Psychiatry (2010) 2.12

A componential analysis of task-switching deficits associated with lesions of left and right frontal cortex. Brain (2004) 2.11

Reflection impulsivity in current and former substance users. Biol Psychiatry (2006) 2.09

The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry (2011) 2.08

The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) (2008) 2.07

Cognitive fitness of cost-efficient brain functional networks. Proc Natl Acad Sci U S A (2009) 2.07

Fetal testosterone influences sexually dimorphic gray matter in the human brain. J Neurosci (2012) 2.05

Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry (2012) 2.05

Decision-making in the adolescent brain. Nat Neurosci (2012) 2.05

Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci (2009) 2.04

Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology (2004) 2.03

Differential activation of the amygdala and the 'social brain' during fearful face-processing in Asperger Syndrome. Neuropsychologia (2006) 2.02

The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours. Psychopharmacology (Berl) (2014) 2.01

Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00

Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology (2010) 1.98

Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98

Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex (2007) 1.95

Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci (2006) 1.95

Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci U S A (2005) 1.94

The rich club of the C. elegans neuronal connectome. J Neurosci (2013) 1.92

Cognitive effort drives workspace configuration of human brain functional networks. J Neurosci (2011) 1.92

Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry (2006) 1.92